Immunotherapy in Advanced Non-Small Cell Lung Cancers: Current Status and Updates-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapy in Advanced Non-Small Cell Lung Cancers: Current Status and Updates

Published:2022-06 Issue: Volume:Volume 14 Page:2079-2090
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Suraya Ratoe^ORCID,Tachihara Motoko^ORCID,Nagano Tatsuya^ORCID,Nishimura Yoshihiro,Kobayashi Kazuyuki

Publisher

Informa UK Limited

Subject

Oncology

Reference60 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Lung Cancer 2020

3. The 2015 World Health Organization Classification of Lung Tumors

4. A review of guidelines for lung cancer

5. Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Durvalumab and taxane family combination therapy enhances the antitumoral effects for NSCLC: An in vitro study;Cell Biochemistry and Function;2024-01

2. Clinicopathological and survival outcomes of 4L lymph node dissection in left lung adenocarcinoma and squamous cell carcinoma;Frontiers in Oncology;2023-04-11

3. Chimeric antigen receptor-T cells are effective against CEACAM5 expressing non-small cell lung cancer cells resistant to antibody-drug conjugates;Frontiers in Oncology;2023-02-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3